Overview

Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.

Status:
Unknown status

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

Summary

To study the effects of rapid escalation of Cabergoline in comparison to conventional dosing in macroprolactinomas. Rapid escalation of cabergoline may help in earlier normalization of prolactin and shrinkage of tumor mass, and thus decrease the cumulative dose of cabergoline altogether.

Phase:

N/A

Details

Lead Sponsor:

Postgraduate Institute of Medical Education and Research

Treatments:

Cabergoline
Dopamine
Dopamine Agonists